---
figid: PMC4746893__13058_2015_661_Fig1_HTML
figtitle: Cyclin D/cyclin-dependent kinase (CDK)4/6/retinoblastoma (Rb) Pathway and
  the cell cycle
organisms:
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
pmcid: PMC4746893
filename: 13058_2015_661_Fig1_HTML.jpg
figlink: /pmc/articles/PMC4746893/figure/Fig1/
number: F1
caption: The cyclin D/cyclin-dependent kinase (CDK)4/6/retinoblastoma (Rb) Pathway
  and the cell cycle. The mammalian cell cycle is tightly regulated. In the context
  of breast cancer, both steroid and peptide growth factors drive proliferation through
  cyclin D/CDK4/6 activation. This results in the hyper-phosporylation of pRb as G1
  progresses. When retinoblastoma protein (pRb) is hyper-phosphorylated, the transcription
  factor E2F is released and the cell cycle progresses through S phase. Small molecule
  kinase inhibitors of CDK4/6 aim to block the hyper-phosphorylation of pRb inducing
  a G1 arrest and preventing proliferation. ER estrogen receptor
papertitle: Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive
  breast cancers.
reftext: Richard S. Finn, et al. Breast Cancer Res. 2016;18:17.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9515371
figid_alias: PMC4746893__F1
figtype: Figure
redirect_from: /figures/PMC4746893__F1
ndex: 61b62f34-def3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4746893__13058_2015_661_Fig1_HTML.html
  '@type': Dataset
  description: The cyclin D/cyclin-dependent kinase (CDK)4/6/retinoblastoma (Rb) Pathway
    and the cell cycle. The mammalian cell cycle is tightly regulated. In the context
    of breast cancer, both steroid and peptide growth factors drive proliferation
    through cyclin D/CDK4/6 activation. This results in the hyper-phosporylation of
    pRb as G1 progresses. When retinoblastoma protein (pRb) is hyper-phosphorylated,
    the transcription factor E2F is released and the cell cycle progresses through
    S phase. Small molecule kinase inhibitors of CDK4/6 aim to block the hyper-phosphorylation
    of pRb inducing a G1 arrest and preventing proliferation. ER estrogen receptor
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TP53
  - TP63
  - TP73
  - CDKN2C
  - UBE2I
  - MAFK
  - EEF1E1
  - ZNF197
  - ATRAID
  - LAMTOR1
  - TPPP2
  - H3P12
  - CDKN2B
  - MRPL28
  - SUB1
  - NXT1
  - H3P9
  - CDKN2A
  - H3P10
  - CDKN2D
  - F9
  - REG1A
  - IL23A
  - H3P13
  - CCND1
  - CDK2
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CDK6
  - CDK4
  - CCNE1
  - CCNE2
  - CCNA1
  - CCNA2
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - WARS1
  - CCNB1
  - CCNB2
  - CCNB3
  - CDK1
  - her
  - Hesr
  - p53
  - betaTub60D
  - hth
  - cac
  - Lamtor1
  - MED21
  - dap
  - Nxt1
  - Zdhhc8
  - Arpc5
  - Su(osk)P16
  - caz
  - l(1)20Ca
  - Cdk2
  - Cdk4
  - CycE
  - LanB2
  - anon-70Db
  - CycA
  - rb
  - ebi
  - E2f2
  - E2f1
  - anon-70Dc
  - CycB
  - Cdk1
  - pnt
  - tp53
  - cdkn2a/b
  - nsg2
  - ccnd1
  - cdk2
  - cdkn1a
  - cdk6
  - cdk4
  - cdk1
---
